Diana McKeithan
Family · Fairmont, NCNPI 1790784619
Payments from drug & device makers
Across 70 payments — averaging $19.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$344
- Forte Bio-pharma LLC$159
- AstraZeneca$125
- IBSA Pharma Inc.$122
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$119
- Braeburn Inc.$80
- plus $392 from 14 others
What the payments were for
- Food & beverage$1,32999%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 24 | $344 |
| Forte Bio-pharma LLC | 4 | $159 |
| AstraZeneca | 1 | $125 |
| IBSA Pharma Inc. | 6 | $122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $119 |
| Braeburn Inc. | 4 | $80 |
| Valinor Pharma, LLC | 3 | $51 |
| Protega Pharmaceutials Inc | 3 | $45 |
| Abbott | 1 | $40 |
| Vertex | 2 | $39 |
| Indivior Inc. | 2 | $37 |
| Virtus Pharmaceuticals LLC | 2 | $36 |
| Amgen | 2 | $27 |
| Biodelivery Sciences International, Inc. | 2 | $25 |
| AbbVie | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Pfizer | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$125
How this compares
$1,341 in reported general payments places this provider in the 75th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 512 | $417,528 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,032 | $142,421 |
| BelbucaBuprenorphine Hcl | 130 | $100,782 |
| Diclofenac Sodium | 130 | $54,591 |
| Levorphanol Tartrate | 13 | $54,145 |
| LinzessLinaclotide | 92 | $49,775 |
| RelistorMethylnaltrexone Bromide | 18 | $44,168 |
| Buprenorphine | 125 | $38,708 |
| Nucynta ErTapentadol Hcl | 15 | $35,105 |
| BrixadiBuprenorphine | 17 | $31,248 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 33 | $26,926 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 35 | $24,287 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 816 | $23,260 |
| Diclofenac Epolamine | 41 | $21,812 |
| GraliseGabapentin | 26 | $18,189 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta Er | $344 | $553,415657 claims |
| Virtus Pharmaceuticals LLCLevorphanol Tartrate | $36 | $54,14513 claims |
| AbbVieLinzess | $21 | $49,77592 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $119 | $44,16818 claims |
| Braeburn Inc.Brixadi | $80 | $31,24817 claims |
| Indivior Inc.Suboxone | $37 | $24,28735 claims |
| Almatica Pharma LLCGralise | $12 | $18,18926 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $13 | $12,40913 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $12 | $11,21923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,522 family providers in North Carolina.
Other family in Fairmont
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
- Debra ScottCharlotte$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.